March 2012
Volume 53, Issue 14
Free
ARVO Annual Meeting Abstract  |   March 2012
The Prevalence of Primary Angle Closure Glaucoma in European Derived Populations
Author Affiliations & Notes
  • Alexander C. Day
    Epidemiology, UCL Institute of Ophthalmology, London, United Kingdom
  • Gianluca Baio
    Department of Statistical Science, University College London, London, United Kingdom
  • Gus Gazzard
    Epidemiology, UCL Institute of Ophthalmology, London, United Kingdom
  • Catey Bunce
    Moorfields Eye Hospital, London, United Kingdom
  • Augusto Azuara-Blanco
    Health Services Research Unit, University of Aberdeen, Aberdeen, United Kingdom
  • Beatriz E. Munoz
    Ophthalmology, Johns Hopkins Wilmer Eye Inst, Baltimore, Maryland
  • David S. Friedman
    Ophthalmology, Johns Hopkins Wilmer Eye Inst, Baltimore, Maryland
  • Paul J. Foster
    Epidemiology, UCL Institute of Ophthalmology, London, United Kingdom
  • Footnotes
    Commercial Relationships  Alexander C. Day, None; Gianluca Baio, None; Gus Gazzard, None; Catey Bunce, None; Augusto Azuara-Blanco, None; Beatriz E. Munoz, None; David S. Friedman, None; Paul J. Foster, None
  • Footnotes
    Support  Fight for Sight
Investigative Ophthalmology & Visual Science March 2012, Vol.53, 4487. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      Alexander C. Day, Gianluca Baio, Gus Gazzard, Catey Bunce, Augusto Azuara-Blanco, Beatriz E. Munoz, David S. Friedman, Paul J. Foster; The Prevalence of Primary Angle Closure Glaucoma in European Derived Populations. Invest. Ophthalmol. Vis. Sci. 2012;53(14):4487.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose: : To estimate the prevalence of primary angle closure glaucoma (PACG) in European derived populations.

Methods: : Systematic review and modeling of PACG prevalence data from population studies. PACG was defined according to the ISGEO definition requiring structural ± functional evidence of glaucomatous optic neuropathy. Prevalence estimates were applied to the 2010 United Nations projected population figures to estimate case numbers.

Results: : The prevalence of PACG in those 40 years old or more is 0.4% (95% CI 0.3 to 0.5). Age-specific prevalence values are 0.02% (CI 0.00 to 0.08) for those 40-49 years, 0.60% (0.27 to 1.00) for those 50-59 years old, 0.20% (0.06 to 0.42) for those 60-69 years old and 0.94% (0.63 to 1.35) for those 70 years old and older. Three-quarters of all cases occur in females (3.25 female: 1 male; CI 1.76 to 5.94).

Conclusions: : This analysis provides a current evidence-based estimate of PACG prevalence in European derived populations and suggests PACG is up to 4 times more common than previously thought. There are an estimated 130,000 people in the United Kingdom, 1.60 million people in Europe and 581,000 people in the United States with PACG today. Accounting for aging population structures, cases are predicted to increase by 19% in the UK, 9% in Europe and 18% in the United States within the next decade.

Keywords: clinical (human) or epidemiologic studies: prevalence/incidence 
×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×